Cargando…
Progress in treatment of ANCA-associated vasculitis
Autoantibodies to neutrophil cytoplasmic antigen-associated vasculitis (AAV) is characterised by inflammation of blood vessels. The introduction of immunosuppressive therapy with glucocorticoids and cyclophosphamide transformed AAV from a fatal condition to a largely treatable condition. Over the pa...
Autores principales: | Smith, Rona M, Jones, Rachel B, Jayne, David RW |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446448/ https://www.ncbi.nlm.nih.gov/pubmed/22569190 http://dx.doi.org/10.1186/ar3797 |
Ejemplares similares
-
ANCA-Associated Vasculitis: An Update
por: Almaani, Salem, et al.
Publicado: (2021) -
High risk of stroke in ANCA-associated vasculitis—a population-based study
por: Tabakovic, Dennis, et al.
Publicado: (2022) -
The COVID-19 pandemic and ANCA-associated vasculitis – reports from the EUVAS meeting and EUVAS education forum
por: Kronbichler, Andreas, et al.
Publicado: (2021) -
Long-term maintenance rituximab for ANCA-associated vasculitis: relapse and infection prediction models
por: McClure, Mark E, et al.
Publicado: (2020) -
The immunopathology of ANCA-associated vasculitis
por: McKinney, Eoin F., et al.
Publicado: (2014)